CoChat
Sign Up
Cited by 199Treatment of Major DepressionPsychotherapy Techniques and ApplicationsMental Health Treatment and Access

The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.

Sertraline and/or interpersonal psychotherapy for patients with dysthymic disorder in primary care: 6-month comparison with longitudinal 2-year follow-up of effectiveness and costs

Browne, Gina, Steiner, Meir, Roberts, Jacqueline, Gafni, Amiram, Byrne, Carolyn, Dunn, Edward, Bell, Barbara, Mills, Michael, Chalklin, Lori, Wallik, David, Kraemer, James·2002·Journal of Affective Disorders
DOI 10.1016/s0165-0327(01)00343-3
Open this paper in CoChat — free account

Abstract

Background There is little information on the long-term effects and costs of a combination of Sertraline and interpersonal psychotherapy (IPT) for the treatment of dysthymia in primary care.Methods In a single-blind, randomized clinical trial, 707 adults (18-74 years of age inclusive) with DSM-IV dysthymic disorder, with or without past and/or current major depression, as an acute or chronic episode, in a community-based primary care practice in Ontario, Canada, were randomized to treatment with either Sertraline alone (50-200 mg), or IPT alone (10 sessions), or Sertraline plus IPT combined. In the acute treatment phase (first 6 months) all groups received full active treatment. This was followed by an additional 18-month naturalistic follow-up phase. Subjects were assessed for effectiveness of treatment in reducing depressive symptoms using the Montgomery Asberg Depression Rating Scale (MADRS) at 6 months and twice again during the 18-month follow-up by blind independent observers. Treatment costs and subjects' use of other health and social services were also investigated.Results At 6 months, 586 subjects completed the MADRS questionnaire. There was a significant difference (P=0.025) in mean MADRS scores: 14.3 (Group I); 14.9 (Group II); 16.8 (Group III), using analysis of covariance. Response (40% improvement) rates were 60.2% for Sertraline alone, 46.6% for IPT alone, and 57.5% for Sertraline augmented by IPT (P=0.02). At 2 years, 525 subjects were retained for follow-up. There was no statistically significant difference between Sertraline alone and Sertraline plus IPT in symptom reduction. However, both were more effective than IPT alone in reducing depressive symptoms (P=0.03). There was a statistically significant difference between groups in costs for use of health and social services. The IPT treatment groups had the lower costs for use of health and social services.Conclusions Sertraline or Sertraline plus IPT was more effective than IPT alone after 6 months. Over the long term (2 years), all three treatments provide reasonably effective treatment for reducing symptoms of dysthymia, but Sertraline or combining Sertraline with IPT is more effective than IPT alone. Of these two more effective treatments, subjects in the Sertraline plus IPT group had less health and social service costs by $480 per person over 2 years. These findings underscore the effects of combining pharmacotherapy and psychotherapy and the economic value of this more comprehensive treatment of dysthymia in primary care.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0165-0327(01)00343-3

Cites

67 of 67 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 2

  1. 1993, Practice guidelines for major depressive disorder in adults, Am. J. Psychiatry, 150, 1
  2. Koran, 1996, Sertraline or imipramine for chronic depression: 7 month results, Psychopharmacol. Bull., 32, 396

Cited by

Sorted by citations

See all 199

Related

See all

Metadata

Authors
Browne, G., Steiner, M., Roberts, J., Gafni, A., Byrne, C., Dunn, E., Bell, B., Mills, M., Chalklin, L., Wallik, D., & Kraemer, J.
Affiliations
  • McMaster University (CA)
  • St. Joseph’s Healthcare Hamilton (CA)
  • University of Toronto (CA)
Corresponding author
Browne, Gina
ORCID
Venue
Journal of Affective Disorders
Publisher
Elsevier BV
Published
2002-04
Volume
68
Issue
2-3
Pages
317-330
ISSN
0165-0327 (ISSN-L)
DOI
10.1016/s0165-0327(01)00343-3
OpenAlex
W2038701603
Cited by
199
References
65
Citations by year
2026: 2 · 2025: 1 · 2024: 7 · 2023: 3 · 2022: 2 · 2021: 3 · 2020: 7 · 2019: 5 · 2018: 1 · 2017: 4 · 2016: 6 · 2015: 9 · 2014: 10 · 2013: 14 · 2012: 9
FWCI
7.32
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Journal of Affective Disorders (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Pfizer
  • Medical Research Council
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
Keywords
sertraline, interpersonal psychotherapy, dysthymia, major depressive disorder, combination pharmacotherapy, antidepressant augmentation, long-term treatment effectiveness, treatment costs, primary care, naturalistic follow-up, depressive symptoms, treatment response rate, relapse prevention, Ontario, Canada
MeSH terms
Adolescent, Adult, Aged, Canada, Combined Modality Therapy, Cost-Benefit Analysis, Depressive Disorder, Major, Major Depressive Disorder, Female, Follow-Up Studies, Humans, Male, Middle Aged, Patient Care Team, Primary Health Care, Psychotherapy, Single-Blind Method, Treatment Outcome, Dysthymic Disorder, Sertraline

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review